Healthcare Sector

ABBV

Market Tracker

$181.33
+0.98
(+0.54%)
1:40 pm
Next Earnings: (est.) 07/27/23 12:00 am
  • ABBV (Selected)

    AbbVie Inc.

ABBV Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

ABBV Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

ABBV Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

ABBV Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

ABBV Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

ABBV Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
08/16/2024 CALL $210.00 223 +157 +237.88%
06/21/2024 CALL $185.00 1,376 +137 +11.06%
08/16/2024 PUT $165.00 545 +124 +29.45%
06/21/2024 PUT $160.00 1,052 +118 +12.63%
04/19/2024 PUT $177.50 354 +100 +39.37%
01/17/2025 CALL $145.00 10,415 +100 +0.97%
03/28/2024 PUT $175.00 773 -50 -6.08%
03/28/2024 CALL $177.50 1,178 -60 -4.85%
03/28/2024 CALL $180.00 1,195 -63 -5.01%
05/17/2024 CALL $155.00 729 -73 -9.10%
04/19/2024 CALL $175.00 3,720 -74 -1.95%
04/19/2024 CALL $180.00 6,933 -248 -3.45%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

ABBV Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.05% 53.76M 7.26B
Vanguard 500 Index Fund 2.32% 40.88M 5.52B
Fidelity 500 Index Fund 1.10% 19.39M 2.62B
SPDR S&P 500 ETF Trust 1.09% 19.15M 2.58B
American Mutual Fund Inc 1.00% 17.6M 2.38B
iShares Core S&P 500 ETF 0.89% 15.78M 2.13B
Vanguard Index-Value Index Fund 0.87% 15.28M 2.06B
Capital Income Builder, Inc. 0.84% 14.87M 2.01B
Select Sector SPDR Fund-Health Care 0.81% 14.36M 1.94B
Washington Mutual Investors Fund 0.75% 13.22M 1.78B

ABBV News

  • U.S. Wide-Moat Stocks On Sale - The March 2024 Heat Map

    03/27 02:09 am

    Seeking Alpha

    Read more
  • AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio

    03/26 10:03 am

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Advances While Market Declines: Some Information for Investors

    03/25 05:45 pm

    Zacks Investment Research

    Read more
  • Nasdaq Turns Higher; Akanda Shares Plunge

    03/25 03:00 pm

    Benzinga

    Read more
  • Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    03/25 02:44 pm

    Benzinga

    Read more
  • Crude Oil Moves Higher; US New Home Sales Fall In February

    03/25 11:54 am

    Benzinga

    Read more
  • Why AbbVie (ABBV) is a Great Dividend Stock Right Now

    03/25 11:45 am

    Zacks Investment Research

    Read more
  • US Stocks Down; Chicago Fed National Activity Index Rises In February

    03/25 09:42 am

    Benzinga

    Read more
  • 3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

    03/25 09:10 am

    Zacks Investment Research

    Read more
  • Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

    03/25 09:00 am

    Zacks Investment Research

    Read more
  • The Latest Analyst Ratings For AbbVie

    03/22 03:01 pm

    Benzinga

    Read more
  • Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now?

    03/20 06:20 am

    Zacks Investment Research

    Read more
  • The Zacks Analyst Blog Highlights Mastercard, AbbVie, Salesforce, Thermo Fisher Scientific and Mondelez

    03/20 05:48 am

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider

    03/19 05:45 pm

    Zacks Investment Research

    Read more
  • Top Analyst Reports for Mastercard, AbbVie & Salesforce

    03/19 12:45 pm

    Zacks Investment Research

    Read more
  • Strike While The Market Is Hot

    03/19 01:45 am

    Seeking Alpha

    Read more
  • Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

    03/18 09:10 am

    Zacks Investment Research

    Read more
  • More Big Changes To My Dividend Growth Portfolio

    03/18 06:46 am

    Seeking Alpha

    Read more
  • 2 Top Dividend Stocks to Buy Hand Over Fist

    03/17 08:15 am

    The Motley Fool

    Read more
  • We're Avoiding Nightmares With SCHD

    03/15 03:30 pm

    Seeking Alpha

    Read more
  • Why AbbVie (ABBV) Dipped More Than Broader Market Today

    03/13 05:45 pm

    Zacks Investment Research

    Read more
  • How Much a $1 Million Portfolio Would Pay in Dividends

    03/13 08:24 am

    The Motley Fool

    Read more
  • 3 Dividend Kings to Navigate Market Volatility With Steady Cashflow, Growth

    03/11 01:30 pm

    Investing.com

    Read more
  • 3 Pharmaceutical Stocks to Buy Hand Over Fist in March

    03/11 09:28 am

    The Motley Fool

    Read more
  • Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

    03/11 09:10 am

    Zacks Investment Research

    Read more
  • The AI Race Gets Litigious

    03/09 10:00 am

    The Motley Fool

    Read more
  • Have $2,500? 2 Superior Growth Stocks to Buy in 2024

    03/09 03:59 am

    The Motley Fool

    Read more
  • Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio

    03/08 12:45 pm

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Stock Slides as Market Rises: Facts to Know Before You Trade

    03/07 06:45 pm

    Zacks Investment Research

    Read more
  • State of the Union: You’ll want to pay attention to this part

    03/07 11:50 am

    MarketWatch

    Read more
  • Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?

    03/05 07:20 am

    Zacks Investment Research

    Read more
  • How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks

    03/04 10:10 am

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Beats Stock Market Upswing: What Investors Need to Know

    03/01 06:45 pm

    Zacks Investment Research

    Read more
  • AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

    03/01 10:00 am

    Zacks Investment Research

    Read more
  • Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields

    03/01 08:52 am

    Benzinga

    Read more
  • C3.ai's (AI) Stock Is Soaring After Earnings But is it Time to Buy?

    02/29 06:22 pm

    Zacks Investment Research

    Read more
  • Better Dividend Growth Stock: AbbVie or Amgen?

    02/29 10:45 am

    The Motley Fool

    Read more
  • Pharma Stock Roundup: FDA Priority Tag to SNY, ABBV Filings, CHMP Nod for AZN, JNJ, MRK

    02/29 09:50 am

    Zacks Investment Research

    Read more
  • Is AbbVie Stock a Buy Now?

    02/29 09:00 am

    The Motley Fool

    Read more
  • Is iShares Core High Dividend ETF (HDV) a Strong ETF Right Now?

    02/29 07:20 am

    Zacks Investment Research

    Read more
  • Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?

    02/28 07:20 am

    Zacks Investment Research

    Read more
  • 3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade

    02/27 06:45 am

    The Motley Fool

    Read more
  • How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks

    02/26 10:10 am

    Zacks Investment Research

    Read more
  • A $100,000 Dividend Snowball From A 5.5%-Yielding All-Weather Portfolio

    02/25 05:00 pm

    Seeking Alpha

    Read more
  • 3 Dividend Stocks That Are No-Brainer Buys Right Now

    02/24 08:04 am

    The Motley Fool

    Read more
  • Pharma Stock Roundup: Pfizer's Velsipity Receives EU Nod, ABBV Gets New CEO & More

    02/23 09:37 am

    Zacks Investment Research

    Read more
  • Is AbbVie Stock a Buy Now?

    02/22 06:15 am

    The Motley Fool

    Read more
  • AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy?

    02/21 12:45 pm

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Announces Appointment of New CEO Robert Michael

    02/21 11:43 am

    Zacks Investment Research

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: